ReviewExperimental biology and medicine (Maywood, N.J.)2018

Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus.

Rachel J Fenske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.